74 related articles for article (PubMed ID: 24595077)
1. Heterogeneous nuclear ribonucleoprotein U-like 1 and Poly (ADP-ribose) polymerase 1 are downregulated in renal cell carcinoma and connected with the prognosis.
Xu T; Zou Q; Wu J; Yu B; Xu Z; Cai H; Zhang W
Cancer Biomark; 2013 Jan; 13(6):411-5. PubMed ID: 24595077
[TBL] [Abstract][Full Text] [Related]
2. The role of hnRPUL1 involved in DNA damage response is related to PARP1.
Hong Z; Jiang J; Ma J; Dai S; Xu T; Li H; Yasui A
PLoS One; 2013; 8(4):e60208. PubMed ID: 23577092
[TBL] [Abstract][Full Text] [Related]
3. Polybromo-1 (PBRM1), a SWI/SNF complex subunit is a prognostic marker in clear cell renal cell carcinoma.
da Costa WH; Rezende M; Carneiro FC; Rocha RM; da Cunha IW; Carraro DM; Guimaraes GC; de Cassio Zequi S
BJU Int; 2014 May; 113(5b):E157-63. PubMed ID: 24053427
[TBL] [Abstract][Full Text] [Related]
4. WWOX protein expression varies among RCC histotypes and downregulation of WWOX protein correlates with less-favorable prognosis in clear RCC.
Lin JT; Tzai TS; Liao CY; Wang JS; Wu TT; Wang HY; Wu CH; Yu CC; Lu PJ
Ann Surg Oncol; 2013 Jan; 20(1):193-9. PubMed ID: 22555346
[TBL] [Abstract][Full Text] [Related]
5. miRNA-205 is a candidate tumor suppressor that targets ZEB2 in renal cell carcinoma.
Chen Z; Tang ZY; He Y; Liu LF; Li DJ; Chen X
Oncol Res Treat; 2014; 37(11):658-64. PubMed ID: 25427583
[TBL] [Abstract][Full Text] [Related]
6. Differential BCCIP gene expression in primary human ovarian cancer, renal cell carcinoma and colorectal cancer tissues.
Liu X; Cao L; Ni J; Liu N; Zhao X; Wang Y; Zhu L; Wang L; Wang J; Yue Y; Cai Y; Jin J
Int J Oncol; 2013 Dec; 43(6):1925-34. PubMed ID: 24101097
[TBL] [Abstract][Full Text] [Related]
7. Negative prognostic value of high levels of intracellular poly(ADP-ribose) in non-small cell lung cancer.
Michels J; Adam J; Goubar A; Obrist F; Damotte D; Robin A; Alifano M; Vitale I; Olaussen KA; Girard P; Cremer I; Castedo M; Soria JC; Kroemer G
Ann Oncol; 2015 Dec; 26(12):2470-7. PubMed ID: 26387143
[TBL] [Abstract][Full Text] [Related]
8. Roles of DNA damage repair and precise targeted therapy in renal cancer (Review).
Lai Y; Li Z; Lu Z; Zheng H; Chen C; Liu C; Yang Y; Tang F; He Z
Oncol Rep; 2022 Dec; 48(6):. PubMed ID: 36263616
[TBL] [Abstract][Full Text] [Related]
9. PARP1 impact on DNA repair of platinum adducts: preclinical and clinical read-outs.
Olaussen KA; Adam J; Vanhecke E; Vielh P; Pirker R; Friboulet L; Popper H; Robin A; Commo F; Thomale J; Kayitalire L; Filipits M; Le Chevalier T; André F; Brambilla E; Soria JC
Lung Cancer; 2013 May; 80(2):216-22. PubMed ID: 23410825
[TBL] [Abstract][Full Text] [Related]
10. Methylation of the gamma-catenin gene is associated with poor prognosis of renal cell carcinoma.
Breault JE; Shiina H; Igawa M; Ribeiro-Filho LA; Deguchi M; Enokida H; Urakami S; Terashima M; Nakagawa M; Kane CJ; Carroll PR; Dahiya R
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):557-64. PubMed ID: 15701841
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of HNF-1B in renal cell carcinoma is associated with tumor progression and poor prognosis.
Buchner A; Castro M; Hennig A; Popp T; Assmann G; Stief CG; Zimmermann W
Urology; 2010 Aug; 76(2):507.e6-11. PubMed ID: 20538322
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of Smac/DIABLO expression in renal cell carcinoma and its prognostic significance.
Mizutani Y; Nakanishi H; Yamamoto K; Li YN; Matsubara H; Mikami K; Okihara K; Kawauchi A; Bonavida B; Miki T
J Clin Oncol; 2005 Jan; 23(3):448-54. PubMed ID: 15572731
[TBL] [Abstract][Full Text] [Related]
13. [Expressions of EZH2 and RUNX3 in renal cell carcinoma and their clinical significance].
Wang G; Qin W; Zheng J; Wei M; Zhou X; Wang H; Wen W
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Jan; 29(1):82-4, 88. PubMed ID: 23294722
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of arginine ADP-ribosyltransferase 1 reduces the expression of poly(ADP-ribose) polymerase-1 in colon carcinoma.
Tang Y; Wang YL; Yang L; Xu JX; Xiong W; Xiao M; Li M
Int J Mol Med; 2013 Jul; 32(1):130-6. PubMed ID: 23652727
[TBL] [Abstract][Full Text] [Related]
15. Poly(adenosine diphosphate-ribose) polymerase expression in BRCA-proficient ovarian high-grade serous carcinoma; association with patient survival.
Gan A; Green AR; Nolan CC; Martin S; Deen S
Hum Pathol; 2013 Aug; 44(8):1638-47. PubMed ID: 23574784
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance and therapeutic potential of prostate cancer antigen-1/ALKBH3 in human renal cell carcinoma.
Hotta K; Sho M; Fujimoto K; Shimada K; Yamato I; Anai S; Harada H; Tsujikawa K; Konishi N; Shinohara N; Nakajima Y
Oncol Rep; 2015 Aug; 34(2):648-54. PubMed ID: 26035443
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-inducible factor-2alpha mRNA expression in human renal cell carcinoma.
Sandlund J; Ljungberg B; Wikström P; Grankvist K; Lindh G; Rasmuson T
Acta Oncol; 2009; 48(6):909-14. PubMed ID: 19322701
[TBL] [Abstract][Full Text] [Related]
18. Studies of the expression of human poly(ADP-ribose) polymerase-1 in Saccharomyces cerevisiae and identification of PARP-1 substrates by yeast proteome microarray screening.
Tao Z; Gao P; Liu HW
Biochemistry; 2009 Dec; 48(49):11745-54. PubMed ID: 19877712
[TBL] [Abstract][Full Text] [Related]
19. Expression of human poly (ADP-ribose) polymerase 1 in Saccharomyces cerevisiae: Effect on survival, homologous recombination and identification of genes involved in intracellular localization.
La Ferla M; Mercatanti A; Rocchi G; Lodovichi S; Cervelli T; Pignata L; Caligo MA; Galli A
Mutat Res; 2015 Apr; 774():14-24. PubMed ID: 25779917
[TBL] [Abstract][Full Text] [Related]
20. Analysis of poly(ADP-ribose) polymerase-1 (PARP1) gene alteration in human germ cell tumor cell lines.
Ogino H; Nakayama R; Sakamoto H; Yoshida T; Sugimura T; Masutani M
Cancer Genet Cytogenet; 2010 Feb; 197(1):8-15. PubMed ID: 20113831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]